www.fdanews.com/articles/178000-dt-medtech-gets-ce-marking-and-begins-selling-of-hintermann-series-h3-devices
DT MedTech Gets CE Marking and Begins Selling of Hintermann Series H3 Devices
August 16, 2016
DT MedTech has been granted CE Marking for the Hintermann Series H3 total ankle replacement devices and are now selling and distributing their products outside the U.S. market.
The series includes: the Hintermann series H3 three-piece total ankle replacement prosthesis, which comprises the standard, sensitive, and revision systems; the Kalix II subtalar arthrodesis implant to treat flatfoot deformities; and instrumentation to support the implantable devices.
The Hintermann series product line now is approved for use in 27 countries, including those in the EU. — Cynthia Jessup